Results 121 to 130 of about 2,566,443 (193)

Factors for achieving target serum uric acid levels after initiating urate-lowering therapy in patients with gout: results from the ULTRA registry. [PDF]

Sci Rep, 2023
Do H, Choi HJ, Choi B, Son CN, Kim SH, Choi SR, Kim JH, Kim MJ, Shin K, Kim HO, Song R, Lee SW, Ahn JK, Lee SG, Lee CH, Son KM, Moon KW.   +16 more
europepmc   +1 more source

Early urate-lowering therapy and cardiometabolic risk in adults without documented major cardiometabolic disease: a real-world cohort study. [PDF]

Front Endocrinol (Lausanne)
Huo AP, Wang SI, Leong PY, Wei JC, Hsu TC.   +4 more
europepmc   +1 more source

Elevated serum CA72-4 predicts gout flares during urate lowering therapy initiation: a prospective cohort study. [PDF]

Rheumatology (Oxford), 2023
Hu S, Sun M, Li M, Xue X, Terkeltaub R, Wang C, Wang M, Lu J, Ran Z, Li H, Ji A, Sun W, Li X, He Y, Liu Z, Zhang H, Wang X, Ji X, Dalbeth N, Li C.   +19 more
europepmc   +1 more source

When underlying biology threatens the randomization principle - initial gout flares of urate-lowering therapy. [PDF]

Nat Rev Rheumatol, 2022
Choi HK, Zhang Y, Dalbeth N.
europepmc   +1 more source

Treatment sequence patterns of urate-lowering therapy in Korean patients with gout: A common data model-based study. [PDF]

PLoS One
Kim MJ, Park EG, Kim C, Kang DY, Ryu B, Shin K.   +5 more
europepmc   +1 more source

Atrial Fibrillation Risk and Urate-Lowering Therapy in Patients with Gout: A Cohort Study Using a Clinical Database. [PDF]

Biomedicines, 2022
Liu CH, Huang SC, Yin CH, Huang WC, Chen JS, Chen YS, Gan ST, Tzou SJ, Hsu CT, Wu HM, Wang WH.   +10 more
europepmc   +1 more source

Timing of urate-lowering therapy and risk of kidney failure and mortality in CKD: an application of the parametric G-formula. [PDF]

Clin Kidney J
Ko A, Sim H, Kwon S, Han SH, Abu-Alfa A, Kim DK, Lim CS, Lee JP, Lee W.   +8 more
europepmc   +1 more source

Early urate-lowering therapy in gouty arthritis with acute flares: a double-blind placebo controlled clinical trial. [PDF]

Eur J Med Res, 2023
Yang DH, Chen HC, Wei JC.
europepmc   +1 more source

Urate-lowering therapy and kidney outcomes in patients with chronic kidney disease and hyperuricemia. [PDF]

Signal Transduct Target Ther
Nie S, Zhou S, Chen R, Li L, Sun Y, Liu J, Jin L, Shao X, Pang M, Su L, Luo F, Xu X, Hou FF.   +12 more
europepmc   +1 more source

I83. Population Use of Urate-Lowering Therapy [PDF]

Rheumatology, 2015
openaire   +1 more source